Translational Medicine : Citations & Metrics Report
Articles published in Translational Medicine have been cited by esteemed scholars and scientists all around the world. Translational Medicine has got h-index 15, which means every article in Translational Medicine has got 15 average citations.
Following are the list of articles that have cited the articles published in Translational Medicine.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
32 | 33 | 30 | 30 | 20 | 3 | 4 | 7 | 34 | 22 | 27 | 23 | 32 | 8 |
Research, Review articles and Editorials |
10 | 10 | 12 | 15 | 18 | 3 | 4 | 9 | 25 | 18 | 15 | 23 | 16 | 8 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
4 | 23 | 16 | 14 | 1 | 0 | 0 | 2 | 4 | 4 | 8 | 0 | 1 | 0 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42 | 46 | 71 | 147 | 52 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
60 | 70 | 101 | 116 | 126 | 128 | 123 | 123 | 95 | 64 | 30 | 18 | 4 | 5 |
| Journal total citations count | 1088 |
| Journal impact factor | 5.03 |
| Journal 5 years impact factor | 12.81 |
| Journal cite score | 13.7 |
| Journal h-index | 15 |
| Journal h-index since 2019 | 12 |
Important citations (480)
Tümmler, c. (2019). novel inflammatory mediators in neuroblastoma tumorigenesis. |
|
Cheng, p., driessen, a., tijsma, e., & udipi, k. (2006). ethoxyethyl methacrylate-based copolymers? a novel platform for drug-eluting stent coatings. journal of controlled release, 116(2), e92. |
|
Andrews, j., & mason, j. c. (2007). takayasu's arteritis—recent advances in imaging offer promise. rheumatology, 46(1), 6-15. |
|
Grilli, r., guastaroba, p., & taroni, f. (2007). effect of hospital ownership status and payment structure on the adoption and use of drug-eluting stents for percutaneous coronary interventions. cmaj, 176(2), 185-190. |
|
Tanaka, t., togashi, y., takeuchi, y., higashi, m., fumino, s., & tajiri, t. (2021). immunohistochemical staining of phosphorylated-erk in post-chemotherapeutic samples is a potential predictor of the prognosis of neuroblastoma. pediatric surgery international, 37(2), 287-291. |
|
Yang, c., & burt, h. m. (2006). drug-eluting stents: factors governing local pharmacokinetics. advanced drug delivery reviews, 58(3), 402-411. |
|
Zhang, j., zhao, y., wang, j., sneh, t., yu, q., zhou, x., & gong, c. (2020). nbpf1 independently determine the risk stratification and prognosis of patients with neuroblastoma. genomics, 112(6), 3951-3957. |
|
Tanimoto, t., tazawa, h., ieda, t., nouso, h., tani, m., oyama, t., ... & fujiwara, t. (2020). elimination of mycn-amplified neuroblastoma cells by telomerase-targeted oncolytic virus via mycn suppression. molecular therapy-oncolytics, 18, 14-23. |
|
Bedair, a., & mansour, f. r. (2021). insights into the fda 2018 new drug approvals. current drug discovery technologies, 18(2), 293-306. |
|
Ford, s. m., pedersen, c. j., ford, m. r., kim, j. w., karunamuni, g. h., mcpheeters, m. t., ... & watanabe, m. (2021). folic acid prevents functional and structural heart defects induced by prenatal ethanol exposure. american journal of physiology-heart and circulatory physiology, 320(4), h1313-h1320. |
|
Zafar, a., wang, w., liu, g., wang, x., xian, w., mckeon, f., ... & zhang, r. (2021). molecular targeting therapies for neuroblastoma: progress and challenges. medicinal research reviews, 41(2), 961-1021. |
|
Aschacher, t., baranyi, u., aschacher, o., eichmair, e., messner, b., zimpfer, d., ... & sandner, s. e. (2021). a novel endothelial damage inhibitor reduces oxidative stress and improves cellular integrity in radial artery grafts for coronary artery bypass. frontiers in cardiovascular medicine, 1242. |
|
Nunes-xavier, c. e., zaldumbide, l., aurtenetxe, o., lópez-almaraz, r., lópez, j. i., & pulido, r. (2019). dual-specificity phosphatases in neuroblastoma cell growth and differentiation. international journal of molecular sciences, 20(5), 1170. |
|
Serrano, s. s., sime, w., abassi, y., daams, r., massoumi, r., & jemaà, m. (2020). inhibition of mitotic kinase mps1 promotes cell death in neuroblastoma. scientific reports, 10(1), 1-14. |
|
Liu, y., wang, m., wang, d., fay, w. p., korthuis, r. j., & sowa, g. (2021). elevated post-ischemic tissue injury and leukocyte-endothelial adhesive interactions in mice with global deficiency in caveolin-2: role of pai-1. american journal of physiology-heart and circulatory physiology. |
|
Li, b. b., wang, b., zhu, c. m., tang, d., pang, j., zhao, j., ... & qian, z. r. (2019). cyclin-dependent kinase 7 inhibitor thz1 in cancer therapy. chronic diseases and translational medicine, 5(3), 155-169. |
|
Cheng, h., pan, y., yao, y., zhu, z., chen, j., sun, x., ... & ding, y. (2017). expression and significance of caveolin?1 in hepatitis b virus?associated hepatocellular carcinoma. experimental and therapeutic medicine, 14(5), 4356-4362. |
|
Sasada, m., iyoda, t., asayama, t., suenaga, y., sakai, s., kase, n., ... & fukai, f. (2019). inactivation of beta1 integrin induces proteasomal degradation of myc oncoproteins. oncotarget, 10(48), 4960. |
|
Sobierajska, k., wawro, m. e., ciszewski, w. m., & niewiarowska, j. (2019). transforming growth factor-? receptor internalization via caveolae is regulated by tubulin-?2 and tubulin-?3 during endothelial-mesenchymal transition. the american journal of pathology, 189(12), 2531-2546. |
|
Wang, s., & head, b. p. (2019). caveolin-1 in stroke neuropathology and neuroprotection: a novel molecular therapeutic target for ischemic-related injury. current vascular pharmacology, 17(1), 41-49. |
|